tiprankstipranks
Trending News
More News >
PDS Biotechnology Corporation (PDSB)
NASDAQ:PDSB
US Market

PDS Biotechnology (PDSB) Financial Statements

Compare
800 Followers

PDS Biotechnology Financial Overview

PDS Biotechnology's market cap is currently $51.77M. The company's EPS TTM is $-0.19; its P/E ratio is -1.19; PDS Biotechnology is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $-0.20. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -59.79K$ -57.33K$ 0.00$ 0.00$ 0.00
Operating Income$ -36.32M$ -43.05M$ -41.67M$ -21.44M$ -14.90M
EBITDA$ -33.75M$ -40.09M$ -40.74M$ -21.43M$ -14.89M
Net Income$ -37.61M$ -42.94M$ -40.85M$ -16.92M$ -14.85M
Balance Sheet
Cash & Short-Term Investments$ 41.69M$ 56.56M$ 73.82M$ 65.24M$ 28.84M
Total Assets$ 45.36M$ 59.39M$ 77.01M$ 67.20M$ 30.89M
Total Debt$ 21.83M$ 23.85M$ 23.47M$ 490.35K$ 610.26K
Net Debt$ -19.86M$ -32.71M$ -50.35M$ -64.75M$ -28.23M
Total Liabilities$ 26.35M$ 33.26M$ 33.01M$ 3.99M$ 3.76M
Stockholders' Equity$ 19.00M$ 26.13M$ 44.00M$ 63.21M$ 27.13M
Cash Flow
Free Cash Flow$ -35.06M$ -33.64M$ -25.71M$ -12.49M$ -13.15M
Operating Cash Flow$ -35.03M$ -33.64M$ -25.71M$ -12.49M$ -13.15M
Investing Cash Flow$ -29.00K$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 20.19M$ 16.38M$ 34.29M$ 48.89M$ 29.83M
Currency in USD

PDS Biotechnology Earnings and Revenue History

PDS Biotechnology Debt to Assets

PDS Biotechnology Cash Flow

PDS Biotechnology Forecast EPS vs Actual EPS